Ethic Inc’s Pactiv Evergreen PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-44,727
Closed -$806K – 1314
2025
Q1
$806K Buy
44,727
+1,619
+4% +$28.8K 0.02% 647
2024
Q4
$753K Sell
43,108
-8,990
-17% -$122K 0.02% 678
2024
Q3
$746K Sell
52,098
-20
-0% -$229 0.02% 655
2024
Q2
$590K Buy
52,118
+20
+0% +$266 0.01% 720
2024
Q1
$746K Buy
52,098
+1,264
+2% +$17.9K 0.02% 655
2023
Q4
$697K Buy
50,834
+7,695
+18% +$81K 0.02% 643
2023
Q3
$351K Sell
43,139
-2,858
-6% -$23.4K 0.01% 766
2023
Q2
$348K Buy
45,997
+15,767
+52% +$120K 0.01% 747
2023
Q1
$242K Sell
30,230
-2,901
-9% -$29.8K 0.01% 846
2022
Q4
$376K Buy
33,131
+14,182
+75% +$155K 0.02% 660
2022
Q3
$165K Buy
18,949
+2,856
+18% +$29.7K 0.01% 756
2022
Q2
$160K Buy
+16,093
New +$162K 0.01% 726

Ethic Inc's PTVE Position: Q2 2025 in Review

Ethic Inc sold out of Pactiv Evergreen (PTVE) in Q2 2025, closing a stake of 44,727 shares — an estimated $806K sold.

Ethic Inc first reported a position in PTVE in Q2 2022 and held it in 12 quarters. The position peaked at $806K in Q1 2025. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

  • Ethic Inc reported no remaining Pactiv Evergreen position as of Q2 2025 after selling out during the quarter.
  • Ethic Inc sold 44,727 Pactiv Evergreen shares in Q2 2025, an estimated $806K.
  • Ethic Inc first reported a position in Pactiv Evergreen in Q2 2022 and held it in 12 quarters.
  • Ethic Inc's Pactiv Evergreen position peaked at $806K in Q1 2025.
  • 0 funds tracked by Wall St. Rank held Pactiv Evergreen as of Q2 2025.

Based on Ethic Inc's 13F filing for Q2 2025, filed 30 Jul 2025.